Natera, Inc. (NTRA)

Castleark Management LLC lessened its position in Natera, Inc. (NASDAQ: NTRA) by 19.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Co...

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, and MEDSIR (Medica Scientia Innovation Research), a global leader in oncology rese...

Stanley Druckenmiller is a Wall Street legend whose trades are truly worth tracking due to how consistently he has been winning....

Baird Financial Group Inc. increased its holdings in shares of Natera, Inc. (NASDAQ: NTRA) by 277.8% during the undefined quarter, according to the company in its most recent 13F filing with the SEC. ...

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, together with Alliance Foundation Trials, LLC (AFT) and the Austrian Breast and Co...

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today shared the results from two oral presentations that were presented at the Am...

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stock is trading lower on Friday, despite no company-specific news, likely reacting to Natera Inc.'s (NASDAQ: NTRA) acquisition of cancer diagnostic...

AUSTIN, Texas & BOULDER, Colo.--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, and Foresight Diagnostics, a leader in ultrasensitive molecular r...

Edgestream Partners L.P. lifted its position in Natera, Inc. (NASDAQ: NTRA) by 154.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissio...

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, announced that new data on Signatera will be presented at the 2025 American Societ...